SCHEMBL26215873

SCHEMBL26215873

c1ccc(-c2cc(-c3cccc4c3oc3cccc(-c5nc(-c6ccccc6)nc(-c6ccccc6)n5)c34)c3oc4ccccc4c3c2)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 2/20 0.41
MAPT P10636 9/20 0.38
TSHR P16473 4/20 0.38
LMNA P02545 3/20 0.38
KMT2A Q03164 3/20 0.38
POLB P06746 2/20 0.38
HTT P42858 1/20 0.38
ALDH1A1 P00352 4/20 0.37
KDM4E B2RXH2 3/20 0.37
HPGD P15428 2/20 0.37
PRKDC P78527 2/20 0.36
PIK3CD O00329 1/20 0.36
PIK3CB P42338 1/20 0.36
NPSR1 Q6W5P4 1/20 0.36
HSD17B10 Q99714 3/20 0.35
GGPS1 O95749 1/20 0.35
USP2 O75604 1/20 0.35
MAPK1 P28482 2/20 0.35
TP53 P04637 1/20 0.35
NFKB1 P19838 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26219468 0.99 ALOX5 (0.42) ALOX5MAPTTSHRLMNAKMT2A
SCHEMBL26225744 0.99 ALOX5 (0.42) ALOX5MAPTTSHRLMNAKMT2A
SCHEMBL26222628 0.96 ALOX5 (0.39) ALOX5MAPTTSHRLMNAKMT2A
SCHEMBL26214274 0.95 ALOX5 (0.40) ALOX5MAPTTSHRLMNAKMT2A
SCHEMBL26218521 0.94 ALOX5 (0.42) ALOX5MAPTTSHRLMNAKMT2A
SCHEMBL24928995 0.93 ALOX5 (0.40) ALOX5MAPTTSHRLMNAKMT2A
SCHEMBL26224900 0.93 ALOX5 (0.39) ALOX5MAPTTSHRLMNAKMT2A
SCHEMBL26246556 0.92 ALOX5 (0.38) ALOX5MAPTTSHRLMNAKMT2A
SCHEMBL26213985 0.91 ALOX5 (0.45) ALOX5MAPTTSHRLMNAKMT2A
SCHEMBL20739810 0.91 ALOX5 (0.47) ALOX5MAPTTSHRLMNAKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230357209-A1 HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME, COMPOSITION FOR ORGANIC LAYER OF ORGANIC LIGHT-EMITTING DEVICE, AND METHOD FOR MANUFACTURING ORGANIC LIGHT-EMITTING DEVICE LT MATERIALS CO., LTD. (KR) 2023-11-09 US disclosed
US-20230357209-A1 HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME, COMPOSITION FOR ORGANIC LAYER OF ORGANIC LIGHT-EMITTING DEVICE, AND METHOD FOR MANUFACTURING ORGANIC LIGHT-EMITTING DEVICE LT MATERIALS CO., LTD. (KR) 2023-11-09 US disclosed
EP-4238969-A1 HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME, COMPOSITION FOR ORGANIC LAYER OF ORGANIC LIGHT-EMITTING DEVICE, AND METHOD FOR MANUFACTURING ORGANIC LIGHT-EMITTING DEVICE LT Materials Co., Ltd. (KR) 2023-09-06 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230357209-A1 HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME, COMPOSITION FOR ORGANIC LAYER OF ORGANIC LIGHT-EMITTING DEVICE, AND METHOD FOR MANUFACTURING ORGANIC LIGHT-EMITTING DEVICE CYP1A1, CYP1B1, ODC1 ALOX5 309/4885MAPT 850/4885TSHR 4002/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.